We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Stock options could no longer be the carrot.
- Authors
Lawrence, Stacy
- Abstract
The article informs that recruitment of top executives in US biotechnology companies could soon be hampered by new legislation requiring employee stock option compensation to be treated as an expense, a practice that is closer to most accounting standards in Europe. But biotech companies hope that a more lenient rule or delayed enforcement of the new ruling will help to ease the burden on small companies and retain a key incentive in recruiting experienced managers. The new ruling was issued in mid-December by the Financial Accounting Standards Board, the designated standard-setting organization.
- Subjects
EMPLOYEE recruitment; EMPLOYEE stock options; BIOTECHNOLOGY industries; LEGISLATION; EMPLOYEE benefits; LABOR incentives; BIOTECHNOLOGY
- Publication
Nature Biotechnology, 2005, Vol 23, Issue 2, p157
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0205-157